You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,416 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients
Active, not recruiting
  • Multiple Myeloma
  • Melphalan, Prednisone, Lenalidomide
  • +2 more
  • Torino, TO, Italy
    Division Of Hematology, A.O.U. Città della Salute e della Scienz
2022-03-24
Mar 24, 2022
H
Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide
Active, not recruiting
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
B
MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma
Recruiting
  • Follicular Lymphoma and Marginal Zone Lymphoma
  • Recombinant Humanized Monoclonal Antibody MIL62, lenalinomide
  • lenalinomide
  • Beijing, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
2022-02-13
Feb 13, 2022
S
Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM
Recruiting
  • Smouldering Myeloma
  • Brno, Czechia
  • +15 more
2022-03-22
Mar 22, 2022
A
Maintenance Lenalidomide in Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • Lenalidomide
  • Philadelphia, Pennsylvania
    Jakub Svoboda
2021-10-04
Oct 4, 2021
M
Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma
Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Lenalidomide
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
2022-02-17
Feb 17, 2022
N
Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas
Not yet recruiting
  • Peripheral T-cell Lymphomas (PTCL)
  • Lenalidomide and Gemcitabine (Dose level 11)
  • +3 more
  • Kaohsiung, Taiwan
  • +3 more
2021-11-01
Nov 1, 2021
E
A Study of Teclistamab in Combination With Lenalidomide Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Not yet recruiting
  • Multiple Myeloma
  • Melbourne, Australia
  • +13 more
2022-02-07
Feb 7, 2022
U
Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction - 2016
Completed
  • Acute Myeloid Leukemia
  • Lenalidomide
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill - Lineberger Compreh
2022-01-25
Jan 25, 2022
U
Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma
Active, not recruiting
  • Lymphoma
  • Rituximab
  • Lenalidomide
  • Sacramento, California
    University of California Davis Cancer Center
2021-11-15
Nov 15, 2021
D
A Study of Lenalidomide for Adult Histiocyte Disorders
Active, not recruiting
  • Langerhans Cell Histiocytosis (LCH)
  • +2 more
  • Lenalidomide
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2022-02-11
Feb 11, 2022
K
Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone
Recruiting
  • Multiple Myeloma
  • Busan, Western, Korea, Republic of
    Kosin University Gospel Hospital
2022-03-31
Mar 31, 2022
H
Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide - 2021
Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • Fludarabine, Cyclophosphamide, Rituximab, Lenalidomide
  • Hackensack, New Jersey
    John Theurer Cancer Center at HackensackUMC
2022-03-17
Mar 17, 2022
U
Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
Active, not recruiting
  • Multiple Myeloma
  • Lenalidomide
  • +3 more
  • Chicago, Illinois
  • +2 more
2021-06-29
Jun 29, 2021
N
Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas - 2019
Completed
  • Diffuse Intrinsic Pontine Glioma
  • +2 more
  • Lenalidomide
  • XRT, 54-59.4 Gy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-12-30
Dec 30, 2021
B
PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV
Recruiting
  • EBV Infection
  • PD1 antibody
  • lenalidomide
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
2022-01-04
Jan 4, 2022
W
BiRd vs. Rd as Initial Therapy in Multiple Myeloma
Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +1 more
2022-02-01
Feb 1, 2022
F
Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Active, not recruiting
  • Plasma Cell Myeloma
  • Transplant-Related Carcinoma
  • Ixazomib Citrate
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
2022-04-04
Apr 4, 2022
M
Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission - 2021
Completed
  • Alkylating Agent-Related Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Laboratory Biomarker Analysis
  • Lenalidomide
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-17
Dec 17, 2021
W
Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL - 2020
Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • New York, New York
    Weill Cornell Medical College
2021-12-23
Dec 23, 2021
U
Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome - 2021
Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Lenalidomide
  • Sacramento, California
    University of California Davis
2022-03-08
Mar 8, 2022
P
Lenalidomide and Dexamethasone for Rosai-Dorfman Disease
Recruiting
  • Rosai-Dorfman Disease
  • lenalidomide and dexamethasone
  • Beijing, China
    Peking Union Medical College Hospital
2021-06-11
Jun 11, 2021
J
Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors - 2018
Terminated
Has Results
  • Central Nervous System Tumors
  • 25 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®)
  • +4 more
  • Saint Petersburg, Florida
    Johns Hopkins All Childen's Hospital
2021-03-08
Mar 8, 2021
U
Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma
Active, not recruiting
  • Non Hodgkin's Lymphoma
  • Sacramento, California
  • +1 more
2021-11-15
Nov 15, 2021
T
Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma
Recruiting
  • Relapsed/Refractory Peripheral T-cell Lymphoma
  • Anti-PD-1 monoclonal antibody
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
2021-12-21
Dec 21, 2021